Impact of a European Training Program for Robotic Liver Surgery (LIVEROBOT)

Launched by AMSTERDAM UMC, LOCATION VUMC · Feb 8, 2023

Keywords

ClinConnect Summary

The LIVEROBOT trial is designed to study a new training program for surgeons in Europe who want to learn advanced robotic techniques for performing liver surgeries. This program is aimed at improving the safety and effectiveness of robotic liver surgery, which can be less invasive and lead to quicker recovery times for patients. The trial will collect information on the outcomes of patients who have surgery during the training process, helping to improve surgical practices over time.

To be eligible for this trial, patients must be at least 18 years old and need surgery for conditions related to the liver or bile ducts, such as cancer or other growths. It’s important that the surgeons involved have significant experience in liver surgery to ensure high-quality care. If you or a family member are considering participation, you can expect to receive a thorough evaluation from both the surgeon and anesthesiologist to ensure it’s safe to proceed with the operation. Please note that women who are pregnant cannot participate in this study.

Gender

ALL

Eligibility criteria

• Center/Surgeon Eligibility Criteria:
• • Prior to admission to the LIVEROBOT training program surgeons must demonstrate laparoscopic experience with a laparoscopic cholecystectomy with OSATS score \>3 (reviewed by proctors), participation in the LAELIVE training program or demonstrating more than two-year experience in clinical laparoscopic liver surgery. Additionally, a minimal surgical volume is required for participation. Annual liver surgery volume (open and minimally invasive combined) per two surgeons should be more 60, aiming to reach more than 40 RLS annually. Each participating surgeon should individually perform a minimum of more than 15 hepatectomy procedures annually. Surgeons shall be excluded from the training program if at any point failing to meet the minimal volume criteria (corrected for COVID-19 restrictions).
• Inclusion Criteria:
• • Age equal or above 18 years
• • Eligible for elective minimally invasive and open hepatectomy for malignant, pre-malignant or benign disease located in the liver or biliary tract
• • Eligible for both minimally invasive and open surgery according to the operating surgeon
• • Fit to undergo the indicated operation according to both the anaesthesiologist and surgeon
• Exclusion Criteria:
• • Pregnancy